Results 231 to 240 of about 729,106 (378)
ABSTRACT Background Residential proximity to commercial pesticide application has been associated with increased odds of developing chronic rhinosinusitis (CRS) with in vitro studies demonstrating cytotoxic dose‐dependent effects on sinonasal epithelia.
Melodyanne Y. Cheng+8 more
wiley +1 more source
Strategies for Survival of Staphylococcus aureus in Host Cells. [PDF]
Xu H+8 more
europepmc +1 more source
Staphylococcus aureus in Inflammation and Pain: Update on Pathologic Mechanisms. [PDF]
Rasquel-Oliveira FS+6 more
europepmc +1 more source
Oxidation of glucose, glycerol and acetate by Staphylococcus aureus [PDF]
Dorothy M. Powelson+2 more
openalex +1 more source
Elexacaftor–Tezacaftor–Ivacaftor Improves Sinonasal Outcomes in Young Children With Cystic Fibrosis
ABSTRACT Background Severe chronic rhinosinusitis (CRS) is a near universal manifestation of cystic fibrosis. Elexacaftor/tezacaftor/ivacaftor (ETI) is an oral, small molecule, highly effective Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) corrector–potentiator drug.
Amanda L. Stapleton+10 more
wiley +1 more source
Single‐Cell Force Spectroscopy Uncovers Root Zone‐ and Bacteria‐Specific Interactions
Atomic force microscopy (AFM) was used to investigate at the single‐cell level the reversible primary attachment between plant growth‐promoting rhizobacteria (PGPR) and plant roots. Bacterial affinities are both species‐ and region‐specific along the root, with flagella playing a key role in mediating these interactions.
Yilei Xue+6 more
wiley +2 more sources
Control of morphogenesis during the <i>Staphylococcus aureus</i> cell cycle. [PDF]
Tinajero-Trejo M+11 more
europepmc +1 more source
Method for Restoring and Maintaining Phenol Resistance of Certain Strains of Staphylococcus aureus [PDF]
Thomas C. Grubb, Marguerite A. Edwards
openalex +1 more source
ABSTRACT Background Elexacaftor/tezacaftor/ivacaftor (ETI) is a Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) therapy that improves pulmonary function and chronic rhinosinusitis (CRS) in cystic fibrosis (CF) adults with at least one copy of the F508del CFTR mutation.
Margaux Petitjean+16 more
wiley +1 more source